期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Parameters of a severe disease course in ulcerative colitis 被引量:2
1
作者 Andreas Stallmach Luisa Nickel +9 位作者 Thomas Lehmann Bernd Bokemeyer Martin Bürger Dietrich Hüppe Wolfgang Kruis Susanna Nikolaus Jan C Preiss Andreas Sturm Niels Teich Carsten Schmidt 《World Journal of Gastroenterology》 SCIE CAS 2014年第35期12574-12580,共7页
AIM: To detect high risk patients with a progressive disease course of ulcerative colitis (UC) requiring immunosuppressive therapy (IT).
关键词 Clinical practice PARAMETER Prediction model Ulcerative colitis Inflammatory bowel disease
暂未订购
Anti-Tuberculosis Drug Induced Liver Injury and Ursodeoxycholic Acid
2
作者 Susanne M. Lang Emad Al-Nemnem Helmut Schiffl 《Journal of Tuberculosis Research》 2020年第2期66-72,共7页
Hepatotoxicity induced by standard anti-tuberculosis drugs (isoniazid, rifampicin, pyrazinamide) can result in significant morbidity and, rarely, even mortality. This major adverse side-effect of anti-tuberculosis tre... Hepatotoxicity induced by standard anti-tuberculosis drugs (isoniazid, rifampicin, pyrazinamide) can result in significant morbidity and, rarely, even mortality. This major adverse side-effect of anti-tuberculosis treatment has a negative impact on patient adherence and patient outcomes as well as on tuberculosis control. Early recognition and prompt withdrawal of the offending drugs are the most critical interventions in the management of anti-tuberculosis drug-induced liver injury. No drug or herbal extract has been shown until recently to prevent or reverse anti-tuberculosis drug-induced hepatotoxicity. Ursodeoxycholic acid is the only FDA approved drug for the treatment of primary biliary cholangitis and has also been successfully used in various cholestatic liver diseases. Although still experimental, recent controlled clinical studies suggested that oral administration of ursodeoxycholic acid may prevent the onset of anti-tuberculosis drug-induced liver injury and accelerate the recovery of liver injury. These clinical data are supported by experimental models of anti-tuberculosis drug-induced hepatotoxicity. There is an urgent need for further randomized clinical trials to document the promising hepatoprotective properties of ursodeoxycholic acid. 展开更多
关键词 Ursodeoxycholic Acid HEPATOTOXICITY RIFAMPICIN ISONIAZID PYRAZINAMIDE TUBERCULOSIS
暂未订购
Case Report: Bilateral Pneumothoraces due to Targeted Tumor Therapy with Regorafenib in a Young Woman with Metastatic Colorectal Cancer
3
作者 Tobias Rachow Tim Sandhaus +2 位作者 Thomas Ernst Helmut Schiffl Susanne M. Lang 《Case Reports in Clinical Medicine》 2022年第5期139-145,共7页
Background: Colorectal cancer is one of the most common cancer types, frequently metastasizing into the lungs. Treatment options have been vastly improved over the last years. With the increasing use of targeted thera... Background: Colorectal cancer is one of the most common cancer types, frequently metastasizing into the lungs. Treatment options have been vastly improved over the last years. With the increasing use of targeted therapies, novel and rare adverse effects can be seen. Case Presentation: A 43-year-old woman presented in our oncology department with chest pain and dyspnea. The patient was diagnosed with colorectal cancer seven years earlier and had received chemoradiation, surgery, and multiple chemotherapies before she was started on regorafenib because of progressive pulmonary metastases. Computed tomography scans demonstrated cavitation of former nodular bilateral pulmonary metastases. After drainage and resolution of the right-sided pneumothorax, the patient returned eleven days later with recurrent symptoms caused by left-sided tension pneumothorax. Video-assisted thoracoscopy and bilateral pleurodeses were performed. Persistent air leaks with severe pain and pulmonary infiltrates led to the death of the patient. Conclusions: This case demonstrates the efficacy of oral antiangiogenetic therapy in advanced metastatic colorectal cancer. Nevertheless, it also depicts an important potential side effect by transforming multiple solid lung metastases into cavitations which led to recurrent pneumothoraces. Special attention should be paid to this phenomenon as treatment of these complications can be challenging. 展开更多
关键词 REGORAFENIB PNEUMOTHORAX Pulmonary Metastases Colorectal Cancer
暂未订购
一种SPG4(spastin)编码序列新突变的罕见病理学机制
4
作者 Schickel J. Beetz C. +2 位作者 Frmmel C. T. Deufel 牛亚利 《世界核心医学期刊文摘(神经病学分册)》 2006年第9期8-8,共1页
The authors report a nucleotide substitution (c.1216A>G) in SPG4 (spastin) causing hereditary spastic paraplegia. This apparent missense mutation in the ATPase domain confers aberrant, in-frame splicing and results... The authors report a nucleotide substitution (c.1216A>G) in SPG4 (spastin) causing hereditary spastic paraplegia. This apparent missense mutation in the ATPase domain confers aberrant, in-frame splicing and results in destabilization of mutated transcript. Mutated protein is deficient in microtubule-severing activity but, unlike neighboring mutations, shows regular subcellular localization. The authors’data point to haploinsufficiency rather than a dominant negative effect as the disease-causing mechanism for this mutation. 展开更多
关键词 错义突变 病理学机制 编码序列 遗传性痉挛性截瘫 罕见 突变蛋白 亚细胞定位 ATP酶
暂未订购
First line vs delayed transplantation in myeloma:Certainties and controversies
5
作者 Annamaria Brioli 《World Journal of Transplantation》 2016年第2期321-330,共10页
Since the middle of 1990 s autologous stem cell trans-plantation has been the cornerstone for the treatment of young patients with multiple myeloma(MM). In the last decade the introduction of novel agents such as immu... Since the middle of 1990 s autologous stem cell trans-plantation has been the cornerstone for the treatment of young patients with multiple myeloma(MM). In the last decade the introduction of novel agents such as immunomodulatory drugs(IMi Ds) and proteasome inhibitors(PI), has dramatically changed the therapeutic scenario of this yet incurable disease. Due to the impressive results achieved with IMi Ds and PI both in terms of response rates and in terms of progression free and overall survival, and to the toxicity linked to high dose therapy and autologous stem cell transplantation(ASCT), a burning question nowadays is whether all young patients should be offered autotransplanta-tion up front or if this should be reserved for the time of relapse. This article provides a review of the data available regarding ASCT in MM and of the current opinion of the scientific community regarding its optimal timing. 展开更多
关键词 Autologous stem cell transplantation Immunomodulatory drugs Proteasome inhibitors High dose therapy Multiple myeloma
暂未订购
Novel atypical G protein-coupled receptor(GPCR)-arrestin complexes:a structural snapshot of the barcode hypothesis
6
作者 Jenny C.Filor Edda S.F.Matthees Carsten Hoffmann 《Signal Transduction and Targeted Therapy》 2025年第9期4797-4798,共2页
In a recent study published in Nature by Chen et al.,six novel cryo-EM structures of atypical chemokine receptor 3(ACKR3)complexes with Arrestin2(Arr2,also known asβ-arrestin1)and Arrestin3(Arr3,also known asβ-arres... In a recent study published in Nature by Chen et al.,six novel cryo-EM structures of atypical chemokine receptor 3(ACKR3)complexes with Arrestin2(Arr2,also known asβ-arrestin1)and Arrestin3(Arr3,also known asβ-arrestin2)were resolved using a novel nanobody,Fab7,which stabilizes active arrestin independent of the isoform,interacting receptor or its phosphorylation pattern.1 This work provides critical insights into G protein-coupled receptor(GPCR)–arrestin interactions under specific GPCR kinase(GRK)phosphorylation conditions,allowing an unprecedented direct comparison of these dynamic signaling complexes. 展开更多
关键词 atypical chemokine receptor novel gpcr arrestin complexes cryo em structures ARRESTIN stabilizes active arrestin nanobody ackr fab
暂未订购
Macrophage’s little helper: vitamin A directs alternatively activated monocyte-derived macrophages to tissue-resident macrophages 被引量:1
7
作者 Dirk Schlüter Florian H Heidel 《Cellular & Molecular Immunology》 SCIE CAS CSCD 2017年第10期805-808,共4页
Tissue-resident macrophages originate from the yolk sac in a Myb-independent manner and populate all organs during embryogenesis.These macrophages are a heterogeneous self-renewing population that adapt to the organ-s... Tissue-resident macrophages originate from the yolk sac in a Myb-independent manner and populate all organs during embryogenesis.These macrophages are a heterogeneous self-renewing population that adapt to the organ-specific local environment to contribute to tissue homeostasis.Depending on the age,organ and inflammatory conditions,macrophages that are derived from hematopoietic stem cells(HSCs)in a Myb-dependent manner may also infiltrate organs and develop into tissueresident macrophages. 展开更多
关键词 ORGANS VITAMIN HOMEOSTASIS
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部